
- Pharmaceutical Commerce - April 2009
Returns Process Proves Presence of Counterfeits in US Supply Chain
XStream Systems’ X-ray technology finds fakes in the returns stream
Saying that it has “confirmed” the estimated 1% counterfeit rate in US pharmaceutical distribution (a figure that has been bounced around for nearly a decade without reliable verification), XStream Systems (Sebastian, FL) is also busy in building out a network of technology resellers and services for pharma distributors. Most recently, the National Coalition of Pharmaceutical Distributors (Miami, FL) has agreed to provide the technology at a preferential basis to its members (who, with no little irony, are the non-authorized distributors that are commonly thought of as a source of counterfeit product). Armada Healthcare, a Short Hills, NJ, GPO for specialty pharmacies, has made a similar deal for the members of its network. XStream has also announced client wins with Cumberland Distribution (Nashville, TN) and RDC Inc (Rochester, NY), a member-owned pharma distribution business.
XStream has developed a desktop-sized device, the XT250 analyzer, into which a sample of a pharmaceutical can be
A main source of counterfeit hits, it turns out, are returned products that have been filled with jelly beans, candy or other products—in effect, retailers gaming the returns system to earn credits for products falsely returned. The danger here is that in some cases, those products can legitimately (if they were authentic) be returned into distribution. Further XStream says that whole lots of fake products have occasionally been found.
“It is vital for pharmaceutical distributors to have an effective process to verify and authenticate their products as they receive and ship them to their customers,” notes Alan Clock, XStream SVP. PC
Articles in this issue
over 16 years ago
ClearOrbit Rolls Up More Supply Chain IT Processesover 16 years ago
Automating the Business-Development Processover 16 years ago
SAP and Teradata Partner on Data Warehousingover 16 years ago
Supply Chain Planning Takes on An International Flavorover 16 years ago
Global Pharma Sales Growth Will Flatten to 2.5-3.5% in 2009over 16 years ago
Riding the Biotech Financing Rollercoasterover 16 years ago
Rx-to-OTC Switch Market Will Double Its Recent Growth Rateover 16 years ago
Drug Wholesalers and the Generic Price Warover 16 years ago
Reshaping Biotechnology's Financing Relay RaceNewsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.